78 related articles for article (PubMed ID: 12125711)
21. Pathogenic mechanisms of mitochondrial DNA depletion in patients with HIV-1 infection.
Torre D; Pugliese A
Clin Infect Dis; 2005 Mar; 40(6):905-6. PubMed ID: 15736031
[No Abstract] [Full Text] [Related]
22. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A
J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
[TBL] [Abstract][Full Text] [Related]
24. Current HIV therapeutics: mechanistic and chemical determinants of toxicity.
Chiao SK; Romero DL; Johnson DE
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):53-60. PubMed ID: 19152213
[TBL] [Abstract][Full Text] [Related]
25. The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.
de Mendoza C; Soriano V
Antivir Ther; 2005; 10 Suppl 2():M109-15. PubMed ID: 16152712
[TBL] [Abstract][Full Text] [Related]
26. HIV and mitochondrial toxicity in children.
Foster C; Lyall H
J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.
Côté HC; Yip B; Asselin JJ; Chan JW; Hogg RS; Harrigan PR; O'Shaughnessy MV; Montaner JS
J Infect Dis; 2003 Jun; 187(12):1972-6. PubMed ID: 12792876
[TBL] [Abstract][Full Text] [Related]
28. [New fixed once daily combination as nucleoside backbone. Basis for long-term therapy success].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():66-8. PubMed ID: 16385881
[No Abstract] [Full Text] [Related]
29. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.
López S; Coll O; Durban M; Hernàndez S; Vidal R; Suy A; Morén C; Casademont J; Cardellach F; Mataró D; Miró O; Garrabou G
Antivir Ther; 2008; 13(6):833-8. PubMed ID: 18839784
[TBL] [Abstract][Full Text] [Related]
30. Metabolic complications of HIV therapy.
Chow DC; Day LJ; Souza SA; Shikuma CM
IAPAC Mon; 2006 Sep; 12(9):302-17. PubMed ID: 17378067
[No Abstract] [Full Text] [Related]
31. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial toxicity and lactic acidosis.
Proj Inf Perspect; 2000 Mar; (29):10-1. PubMed ID: 12772662
[TBL] [Abstract][Full Text] [Related]
33. Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.
Miller RF; Shahmonesh M; Hanna MG; Unwin RJ; Schapira AH; Weller IV
Antivir Ther; 2003 Jun; 8(3):253-7. PubMed ID: 12924544
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial toxicity: myths and facts.
Moyle G
J HIV Ther; 2004 May; 9(2):45-7. PubMed ID: 15238876
[TBL] [Abstract][Full Text] [Related]
35. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
[TBL] [Abstract][Full Text] [Related]
36. Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.
Brogly SB; Foca M; Deville JG; Mirochnick M; Scott GB; Mofenson LM; Read JS; Viani RM; Burchett SK; Cooper ER; Browning R; Shapiro DE
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):154-7. PubMed ID: 20035168
[No Abstract] [Full Text] [Related]
37. FDA reviewing safety of Ziagen and Videx.
AIDS Read; 2008 May; 18(5):236. PubMed ID: 18589877
[No Abstract] [Full Text] [Related]
38. A test for mitochondrial toxicity.
Nagy GS
AIDS Clin Care; 2002 May; 14(5):47-8. PubMed ID: 12004881
[No Abstract] [Full Text] [Related]
39. [Delayed drug sensitivity].
del Valle Loarte P; Cervero Jiménez M; Joya Seijo MD; Jusdado Ruiz-Capillas JJ; Torres Perea R
Rev Clin Esp; 2003 Dec; 203(12):617-8. PubMed ID: 14622520
[No Abstract] [Full Text] [Related]
40. Dietary supplements in the treatment of nucleoside reverse transcriptase inhibitor-related mitochondrial toxicity.
Venhoff N; Setzer B; Lebrecht D; Walker UA
AIDS; 2002 Mar; 16(5):800-2. PubMed ID: 11964542
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
